Dr. Jeremy P. Cetnar
Claim this profileOregon Health and Science University
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
11 reported clinical trials
23 drugs studied
Area of expertise
1Non-Small Cell Lung Cancer
Stage IV
Stage III
PD-L1 positive
2Lung Cancer
Stage IV
Stage III
RET positive
Affiliated Hospitals
Clinical Trials Jeremy P. Cetnar is currently running
Ozuriftamab Vedotin
for Head and Neck Cancer
This is a multi-center, open-label Phase 2 study designed to evaluate the efficacy and safety of BA3021 as monotherapy and combination therapy in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
Recruiting1 award Phase 2
Radiation + Immunotherapy
for Non-Small Cell Lung Cancer
This phase II trial studies the side effects of radiation therapy followed by atezolizumab in treating patients with stage II or III non-small cell lung cancer. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may kill more cancer cells and have fewer side effects. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The purpose of this study is to test the safety and effectiveness of radiation therapy followed by atezolizumab and find out what side effects, if any, it has on patient's non-small cell lung cancer.
Recruiting1 award Phase 239 criteria
More about Jeremy P. Cetnar
Clinical Trial Related6 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Jeremy P. Cetnar has experience with
- Pembrolizumab
- Atezolizumab
- Ramucirumab
- NT-I7
- Carboplatin
- Cisplatin
Breakdown of trials Jeremy P. Cetnar has run
Non-Small Cell Lung Cancer
Lung Cancer
Thyroid Cancer
Relapse
Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jeremy P. Cetnar specialize in?
Jeremy P. Cetnar focuses on Non-Small Cell Lung Cancer and Lung Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Jeremy P. Cetnar currently recruiting for clinical trials?
Yes, Jeremy P. Cetnar is currently recruiting for 3 clinical trials in Portland Oregon. If you're interested in participating, you should apply.
Are there any treatments that Jeremy P. Cetnar has studied deeply?
Yes, Jeremy P. Cetnar has studied treatments such as Pembrolizumab, Atezolizumab, Ramucirumab.
What is the best way to schedule an appointment with Jeremy P. Cetnar?
Apply for one of the trials that Jeremy P. Cetnar is conducting.
What is the office address of Jeremy P. Cetnar?
The office of Jeremy P. Cetnar is located at: Oregon Health and Science University, Portland, Oregon 97239-3098 United States. This is the address for their practice at the Oregon Health and Science University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.